297 related articles for article (PubMed ID: 31049843)
1. Delivery of therapeutic miRNA using polymer-based formulation.
Ban E; Kwon TH; Kim A
Drug Deliv Transl Res; 2019 Dec; 9(6):1043-1056. PubMed ID: 31049843
[TBL] [Abstract][Full Text] [Related]
2. Progress in microRNA delivery.
Zhang Y; Wang Z; Gemeinhart RA
J Control Release; 2013 Dec; 172(3):962-74. PubMed ID: 24075926
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs.
Mullick Chowdhury S; Wang TY; Bachawal S; Devulapally R; Choe JW; Abou Elkacem L; Yakub BK; Wang DS; Tian L; Paulmurugan R; Willmann JK
J Control Release; 2016 Sep; 238():272-280. PubMed ID: 27503707
[TBL] [Abstract][Full Text] [Related]
4. Polymer-based delivery of RNA-based therapeutics in ovarian cancer.
Weirauch U; Gutsch D; Höbel S; Aigner A
Methods Mol Biol; 2013; 1049():443-65. PubMed ID: 23913237
[TBL] [Abstract][Full Text] [Related]
5. Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors.
Wang H; Jiang Y; Peng H; Chen Y; Zhu P; Huang Y
Adv Drug Deliv Rev; 2015 Jan; 81():142-60. PubMed ID: 25450259
[TBL] [Abstract][Full Text] [Related]
6. Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology.
Chistiakov DA; Sobenin IA; Orekhov AN
Drug Deliv; 2012 Nov; 19(8):392-405. PubMed ID: 23173580
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs as therapeutics for future drug delivery systems in treatment of lung diseases.
Dua K; Hansbro NG; Foster PS; Hansbro PM
Drug Deliv Transl Res; 2017 Feb; 7(1):168-178. PubMed ID: 27848224
[TBL] [Abstract][Full Text] [Related]
8. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
9. Strategies to antagonize miRNA functions in vitro and in vivo.
Baigude H; Rana TM
Nanomedicine (Lond); 2014 Nov; 9(16):2545-55. PubMed ID: 25490425
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-based therapeutics for cancer.
Wang V; Wu W
BioDrugs; 2009; 23(1):15-23. PubMed ID: 19344188
[TBL] [Abstract][Full Text] [Related]
11. Delivering the promise of miRNA cancer therapeutics.
Pereira DM; Rodrigues PM; Borralho PM; Rodrigues CM
Drug Discov Today; 2013 Mar; 18(5-6):282-9. PubMed ID: 23064097
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-targeted therapeutics for lung cancer treatment.
Xue J; Yang J; Luo M; Cho WC; Liu X
Expert Opin Drug Discov; 2017 Feb; 12(2):141-157. PubMed ID: 27866431
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of miRNA-204-5p by PEGylated polymer nanoparticles for colon cancer therapy.
Zheng B; Chen L; Pan CC; Wang JZ; Lu GR; Yang SX; Xue ZX; Wang FY; Xu CL
Nanomedicine (Lond); 2018 Apr; 13(7):769-785. PubMed ID: 29460671
[TBL] [Abstract][Full Text] [Related]
14. In vivo delivery of miRNAs for cancer therapy: challenges and strategies.
Chen Y; Gao DY; Huang L
Adv Drug Deliv Rev; 2015 Jan; 81():128-41. PubMed ID: 24859533
[TBL] [Abstract][Full Text] [Related]
15. miRNA nanotherapeutics for cancer.
Ganju A; Khan S; Hafeez BB; Behrman SW; Yallapu MM; Chauhan SC; Jaggi M
Drug Discov Today; 2017 Feb; 22(2):424-432. PubMed ID: 27815139
[TBL] [Abstract][Full Text] [Related]
16. Long chain microRNA conjugates in calcium phosphate nanoparticles for efficient formulation and delivery.
Jung H; Kim SA; Yang YG; Yoo H; Lim SJ; Mok H
Arch Pharm Res; 2015; 38(5):705-15. PubMed ID: 25052958
[TBL] [Abstract][Full Text] [Related]
17. Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives.
Mehta M; Satija S; Paudel KR; Malyla V; Kannaujiya VK; Chellappan DK; Bebawy M; Hansbro PM; Wich PR; Dua K
Nanomedicine; 2021 Jan; 31():102303. PubMed ID: 32980549
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Delivery of Tumor Suppressor miRNAs for Breast Cancer Treatment.
Shinde SS; Ahmed S; Malik JA; Hani U; Khanam A; Ashraf Bhat F; Ahmad Mir S; Ghazwani M; Wahab S; Haider N; Almehizia AA
Biology (Basel); 2023 Mar; 12(3):. PubMed ID: 36979159
[TBL] [Abstract][Full Text] [Related]
19. Photoluminescent and biodegradable polycitrate-polyethylene glycol-polyethyleneimine polymers as highly biocompatible and efficient vectors for bioimaging-guided siRNA and miRNA delivery.
Wang M; Guo Y; Yu M; Ma PX; Mao C; Lei B
Acta Biomater; 2017 May; 54():69-80. PubMed ID: 28219808
[TBL] [Abstract][Full Text] [Related]
20. Non-viral nanocarriers for intracellular delivery of microRNA therapeutics.
Bai Z; Wei J; Yu C; Han X; Qin X; Zhang C; Liao W; Li L; Huang W
J Mater Chem B; 2019 Feb; 7(8):1209-1225. PubMed ID: 32255160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
